Neonatal Intensive Care Market By Product (Warmers, Incubators, Monitoring Devices, Respiratory Devices, Phototherapy Equipment, Others), By Application (Neonatal Hypothermia & Low Birth Weight, Jaundice, Others), By End User (Hospitals, Maternity Hospitals, Neonatal & Pediatric Hospital): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global neonatal intensive care market was valued at $2,012.4 million in 2021, and is projected to reach $4,403.0 million by 2031, registering a CAGR of 8.2% from 2022 to 2031.
A neonatal intensive care unit (NICU), also known as an intensive care nursery, is an intensive care unit that specializes in care of ill or premature newborn infants. The common equipment in a neonatal intensive care unit (NICU) include mechanical ventilators to assist breathing through an endotracheal tube or a tracheostomy tube; cardiac monitors for monitoring cardiac condition; equipment for constant monitoring of bodily functions; and a web of intravenous lines, feeding tubes, nasogastric tubes, and suction pumps.
Increase in birth rate and rise in number of preterm births boost growth of the market. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2020, around 3,613,647 newborns were reported. Thus, increase in number of child birth and growth in number of preterm births drive growth of the market.
In addition, increase in incidences of maternity factors such as age of mother, alcoholism, and smoking is responsible for low growth rate and preterm delivery of baby, which further contributes toward growth of the market. Age-related factors such as being younger than 16 and older than age 40 contributes toward rise in underdeveloped child delivery rate. However, the rate of child marriage is slowly falling, owing to increase in awareness about child marriages and strict government initiatives. For instance, according to the United Nations Population Fund (UNFPA), in 2021, one in five women between the ages of 20 and 24 reported they had been married as children. From the same source, the total number of child marriages is projected to increase by 2030, owing to regional and socioeconomic factors.
Furthermore, increase in prevalence of chronic diseases such as diabetes and hypertension contribute toward growth of the market. Diabetes during pregnancy may be associated with a high rate of congenital anomalies, disturbances of intrauterine growth, and often post-natal neurobehavioral abnormalities in offspring. The latter are associated with pregestational (PGD) as well as with gestational diabetes (GD). This associated diseases in newborn may require special attention and admission in neonatal intensive care. For instance, according to the International Diabetes Federation (IDF), In 2021, approximately 537 million adults (20–79 years) were living with diabetes. and the number is projected to rise to 643 million by 2030 and 783 million by 2045.
Moreover, increase in R&D activities for development of advanced neonatal intensive cares such as advanced thermometer & oximeters, rise approvals from the in U.S. Food and Drug administration (USFDA), and novel product launches by key players boost the market growth. For instance, in December 2021, , U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Medtronic plc., a global leader in healthcare technology, for its INVOS 7100 cerebral/somatic oximetry system for children from birth through age 18. Furthermore, growing risk of COVID-19 infections in children propels demand for respiratory devices. However, high cost of neonatal intensive care and product recall hinder growth of the market.
The neonatal intensive care market is segmented on the basis of product, application, end user, and region. By product, the market is classified into warmers, incubators, monitoring devices, respiratory devices, phototherapy equipment, and others. The incubators segment is further divided into hybrid incubator, normal incubator, and transport incubator.
Depending on application the market is classified into neonatal hypothermia & low birth weight, jaundice, and others. By end user, it is categorized into hospitals, maternity hospitals, and neonatal & pediatric hospitals. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Drägerwerk AG & Co. KGaA, GE Company, Masimo Corporation, 3M Company, Phoenix Medical Systems Pvt Ltd., Medtronic PLC, Koninklijke Philips N.V, Fanem Medical Devices, Atom Medica, Mediprema Group, Siemens Healthcare GmbH, Terumo Corporation, Medicor Elektronika, Ningbo David Medical Device Co., Ltd., Zhengzhou Dison Instrument and Meter Co., Ltd, AngioDynamics, and Vygon (UK) Ltd.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the neonatal intensive care market analysis from 2021 to 2031 to identify the prevailing neonatal intensive care market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the neonatal intensive care market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global neonatal intensive care market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Warmers
Incubators
Type
Hybrid Incubator
Normal Incubator
Transport Incubator
Monitoring Devices
Respiratory Devices
Phototherapy Equipment
Others
By Application
Neonatal Hypothermia Low Birth Weight
Jaundice
Others
By End User
Hospitals
Maternity Hospitals
Neonatal Pediatric Hospital
By Region
North America
U.S.
Canada
Mexico
Europe
UK
Italy
Spain
Rest of Europe
Germany
France
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Drägerwerk AG & Co. KGaA
GE Company
Masimo Corporation
3M Company
Phoenix Medical Systems Pvt Ltd.
Medtronic PLC
Koninklijke Philips N.V
Fanem Medical Devices
Atom Medica
Mediprema Group
Siemens Healthcare GmbH
Terumo Corporation
Medicor Elektronika
Ningbo David Medical Device Co., Ltd.
Zhengzhou Dison Instrument And Meter Co., Ltd
AngioDynamics
Vygon (UK) Ltd
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: NEONATAL INTENSIVE CARE MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Warmers
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Incubators
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Incubators Neonatal Intensive Care Market by Type
- 4.3.4.1 Hybrid Incubator Market size and forecast, by region
- 4.3.4.2 Normal Incubator Market size and forecast, by region
- 4.3.4.3 Transport Incubator Market size and forecast, by region
- 4.4 Monitoring Devices
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Respiratory Devices
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- 4.6 Phototherapy Equipment
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
- 4.7 Others
- 4.7.1 Key market trends, growth factors and opportunities
- 4.7.2 Market size and forecast, by region
- 4.7.3 Market analysis by country
- CHAPTER 5: NEONATAL INTENSIVE CARE MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Neonatal Hypothermia & Low Birth Weight
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Jaundice
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Others
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: NEONATAL INTENSIVE CARE MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Maternity Hospitals
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Neonatal & Pediatric Hospital
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: NEONATAL INTENSIVE CARE MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.2.1 North America Incubators Neonatal Intensive Care Market by Type
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product
- 7.2.5.1.2 Market size and forecast, by Application
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product
- 7.2.5.2.2 Market size and forecast, by Application
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product
- 7.2.5.3.2 Market size and forecast, by Application
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.2.1 Europe Incubators Neonatal Intensive Care Market by Type
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product
- 7.3.5.1.2 Market size and forecast, by Application
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Product
- 7.3.5.2.2 Market size and forecast, by Application
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 UK
- 7.3.5.3.1 Market size and forecast, by Product
- 7.3.5.3.2 Market size and forecast, by Application
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Product
- 7.3.5.4.2 Market size and forecast, by Application
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Product
- 7.3.5.5.2 Market size and forecast, by Application
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Product
- 7.3.5.6.2 Market size and forecast, by Application
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.2.1 Asia-Pacific Incubators Neonatal Intensive Care Market by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 China
- 7.4.5.1.1 Market size and forecast, by Product
- 7.4.5.1.2 Market size and forecast, by Application
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 Japan
- 7.4.5.2.1 Market size and forecast, by Product
- 7.4.5.2.2 Market size and forecast, by Application
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Product
- 7.4.5.3.2 Market size and forecast, by Application
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 Australia
- 7.4.5.4.1 Market size and forecast, by Product
- 7.4.5.4.2 Market size and forecast, by Application
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Product
- 7.4.5.5.2 Market size and forecast, by Application
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Product
- 7.4.5.6.2 Market size and forecast, by Application
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.2.1 LAMEA Incubators Neonatal Intensive Care Market by Type
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Product
- 7.5.5.1.2 Market size and forecast, by Application
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Product
- 7.5.5.2.2 Market size and forecast, by Application
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Product
- 7.5.5.3.2 Market size and forecast, by Application
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Product
- 7.5.5.4.2 Market size and forecast, by Application
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Drägerwerk AG & Co. KGaA
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 GE Company
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Masimo Corporation
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 3M Company
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Phoenix Medical Systems Pvt Ltd.
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Medtronic PLC
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Koninklijke Philips N.V
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Fanem Medical Devices
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Atom Medica
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Mediprema Group
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 Siemens Healthcare GmbH
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 Terumo Corporation
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- 9.13 Medicor Elektronika
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
- 9.14 Ningbo David Medical Device Co., Ltd.
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
- 9.15 Zhengzhou Dison Instrument And Meter Co., Ltd
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
- 9.16 AngioDynamics
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
- 9.17 Vygon (UK) Ltd
- 9.17.1 Company overview
- 9.17.2 Company snapshot
- 9.17.3 Operating business segments
- 9.17.4 Product portfolio
- 9.17.5 Business performance
- 9.17.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 2. NEONATAL INTENSIVE CARE MARKET SIZE, FOR WARMERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. NEONATAL INTENSIVE CARE MARKET FOR WARMERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. NEONATAL INTENSIVE CARE MARKET SIZE, FOR INCUBATORS, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. NEONATAL INTENSIVE CARE MARKET FOR INCUBATORS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. GLOBAL INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 7. NEONATAL INTENSIVE CARE MARKET, FOR HYBRID INCUBATOR, BY REGION, 2021-2031 ($MILLION)
- TABLE 8. NEONATAL INTENSIVE CARE MARKET, FOR NORMAL INCUBATOR, BY REGION, 2021-2031 ($MILLION)
- TABLE 9. NEONATAL INTENSIVE CARE MARKET, FOR TRANSPORT INCUBATOR, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. NEONATAL INTENSIVE CARE MARKET SIZE, FOR MONITORING DEVICES, BY REGION, 2021-2031 ($MILLION)
- TABLE 11. NEONATAL INTENSIVE CARE MARKET FOR MONITORING DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 12. NEONATAL INTENSIVE CARE MARKET SIZE, FOR RESPIRATORY DEVICES, BY REGION, 2021-2031 ($MILLION)
- TABLE 13. NEONATAL INTENSIVE CARE MARKET FOR RESPIRATORY DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 14. NEONATAL INTENSIVE CARE MARKET SIZE, FOR PHOTOTHERAPY EQUIPMENT, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. NEONATAL INTENSIVE CARE MARKET FOR PHOTOTHERAPY EQUIPMENT, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 16. NEONATAL INTENSIVE CARE MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. NEONATAL INTENSIVE CARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 18. GLOBAL NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 19. NEONATAL INTENSIVE CARE MARKET SIZE, FOR NEONATAL HYPOTHERMIA & LOW BIRTH WEIGHT, BY REGION, 2021-2031 ($MILLION)
- TABLE 20. NEONATAL INTENSIVE CARE MARKET FOR NEONATAL HYPOTHERMIA & LOW BIRTH WEIGHT, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 21. NEONATAL INTENSIVE CARE MARKET SIZE, FOR JAUNDICE, BY REGION, 2021-2031 ($MILLION)
- TABLE 22. NEONATAL INTENSIVE CARE MARKET FOR JAUNDICE, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 23. NEONATAL INTENSIVE CARE MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 24. NEONATAL INTENSIVE CARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 25. GLOBAL NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 26. NEONATAL INTENSIVE CARE MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
- TABLE 27. NEONATAL INTENSIVE CARE MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 28. NEONATAL INTENSIVE CARE MARKET SIZE, FOR MATERNITY HOSPITALS, BY REGION, 2021-2031 ($MILLION)
- TABLE 29. NEONATAL INTENSIVE CARE MARKET FOR MATERNITY HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 30. NEONATAL INTENSIVE CARE MARKET SIZE, FOR NEONATAL & PEDIATRIC HOSPITAL, BY REGION, 2021-2031 ($MILLION)
- TABLE 31. NEONATAL INTENSIVE CARE MARKET FOR NEONATAL & PEDIATRIC HOSPITAL, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 32. NEONATAL INTENSIVE CARE MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 33. NORTH AMERICA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 34. NORTH AMERICA INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 35. NORTH AMERICA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 36. NORTH AMERICA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 37. NORTH AMERICA NEONATAL INTENSIVE CARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 38. U.S. NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 39. U.S. NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 40. U.S. NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 41. CANADA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 42. CANADA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 43. CANADA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 44. MEXICO NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 45. MEXICO NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 46. MEXICO NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 47. EUROPE NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 48. EUROPE INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 49. EUROPE NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 50. EUROPE NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 51. EUROPE NEONATAL INTENSIVE CARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 52. GERMANY NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 53. GERMANY NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 54. GERMANY NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 55. FRANCE NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 56. FRANCE NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 57. FRANCE NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 58. UK NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 59. UK NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 60. UK NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 61. ITALY NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 62. ITALY NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 63. ITALY NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 64. SPAIN NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 65. SPAIN NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 66. SPAIN NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 67. REST OF EUROPE NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 68. REST OF EUROPE NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 69. REST OF EUROPE NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 70. ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 71. ASIA-PACIFIC INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 72. ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 73. ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 74. ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 75. CHINA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 76. CHINA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 77. CHINA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 78. JAPAN NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 79. JAPAN NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 80. JAPAN NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 81. INDIA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 82. INDIA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 83. INDIA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 84. AUSTRALIA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 85. AUSTRALIA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 86. AUSTRALIA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 87. SOUTH KOREA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 88. SOUTH KOREA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 89. SOUTH KOREA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 90. REST OF ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 91. REST OF ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 92. REST OF ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 93. LAMEA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 94. LAMEA INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 95. LAMEA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 96. LAMEA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 97. LAMEA NEONATAL INTENSIVE CARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 98. BRAZIL NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 99. BRAZIL NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 100. BRAZIL NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 101. SAUDI ARABIA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 102. SAUDI ARABIA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 103. SAUDI ARABIA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 104. SOUTH AFRICA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 105. SOUTH AFRICA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 106. SOUTH AFRICA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 107. REST OF LAMEA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 108. REST OF LAMEA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 109. REST OF LAMEA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 110.DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT
- TABLE 111.DRÄGERWERK AG & CO. KGAA: OPERATING SEGMENTS
- TABLE 112.DRÄGERWERK AG & CO. KGAA: PRODUCT PORTFOLIO
- TABLE 113.DRÄGERWERK AG & CO. KGAA: NET SALES,
- TABLE 114.DRÄGERWERK AG & CO. KGAA: KEY STRATERGIES
- TABLE 115.GE COMPANY: COMPANY SNAPSHOT
- TABLE 116.GE COMPANY: OPERATING SEGMENTS
- TABLE 117.GE COMPANY: PRODUCT PORTFOLIO
- TABLE 118.GE COMPANY: NET SALES,
- TABLE 119.GE COMPANY: KEY STRATERGIES
- TABLE 120.MASIMO CORPORATION: COMPANY SNAPSHOT
- TABLE 121.MASIMO CORPORATION: OPERATING SEGMENTS
- TABLE 122.MASIMO CORPORATION: PRODUCT PORTFOLIO
- TABLE 123.MASIMO CORPORATION: NET SALES,
- TABLE 124.MASIMO CORPORATION: KEY STRATERGIES
- TABLE 125.3M COMPANY: COMPANY SNAPSHOT
- TABLE 126.3M COMPANY: OPERATING SEGMENTS
- TABLE 127.3M COMPANY: PRODUCT PORTFOLIO
- TABLE 128.3M COMPANY: NET SALES,
- TABLE 129.3M COMPANY: KEY STRATERGIES
- TABLE 130.PHOENIX MEDICAL SYSTEMS PVT LTD.: COMPANY SNAPSHOT
- TABLE 131.PHOENIX MEDICAL SYSTEMS PVT LTD.: OPERATING SEGMENTS
- TABLE 132.PHOENIX MEDICAL SYSTEMS PVT LTD.: PRODUCT PORTFOLIO
- TABLE 133.PHOENIX MEDICAL SYSTEMS PVT LTD.: NET SALES,
- TABLE 134.PHOENIX MEDICAL SYSTEMS PVT LTD.: KEY STRATERGIES
- TABLE 135.MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 136.MEDTRONIC PLC: OPERATING SEGMENTS
- TABLE 137.MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 138.MEDTRONIC PLC: NET SALES,
- TABLE 139.MEDTRONIC PLC: KEY STRATERGIES
- TABLE 140.KONINKLIJKE PHILIPS N.V: COMPANY SNAPSHOT
- TABLE 141.KONINKLIJKE PHILIPS N.V: OPERATING SEGMENTS
- TABLE 142.KONINKLIJKE PHILIPS N.V: PRODUCT PORTFOLIO
- TABLE 143.KONINKLIJKE PHILIPS N.V: NET SALES,
- TABLE 144.KONINKLIJKE PHILIPS N.V: KEY STRATERGIES
- TABLE 145.FANEM MEDICAL DEVICES: COMPANY SNAPSHOT
- TABLE 146.FANEM MEDICAL DEVICES: OPERATING SEGMENTS
- TABLE 147.FANEM MEDICAL DEVICES: PRODUCT PORTFOLIO
- TABLE 148.FANEM MEDICAL DEVICES: NET SALES,
- TABLE 149.FANEM MEDICAL DEVICES: KEY STRATERGIES
- TABLE 150.ATOM MEDICA: COMPANY SNAPSHOT
- TABLE 151.ATOM MEDICA: OPERATING SEGMENTS
- TABLE 152.ATOM MEDICA: PRODUCT PORTFOLIO
- TABLE 153.ATOM MEDICA: NET SALES,
- TABLE 154.ATOM MEDICA: KEY STRATERGIES
- TABLE 155.MEDIPREMA GROUP: COMPANY SNAPSHOT
- TABLE 156.MEDIPREMA GROUP: OPERATING SEGMENTS
- TABLE 157.MEDIPREMA GROUP: PRODUCT PORTFOLIO
- TABLE 158.MEDIPREMA GROUP: NET SALES,
- TABLE 159.MEDIPREMA GROUP: KEY STRATERGIES
- TABLE 160.SIEMENS HEALTHCARE GMBH: COMPANY SNAPSHOT
- TABLE 161.SIEMENS HEALTHCARE GMBH: OPERATING SEGMENTS
- TABLE 162.SIEMENS HEALTHCARE GMBH: PRODUCT PORTFOLIO
- TABLE 163.SIEMENS HEALTHCARE GMBH: NET SALES,
- TABLE 164.SIEMENS HEALTHCARE GMBH: KEY STRATERGIES
- TABLE 165.TERUMO CORPORATION: COMPANY SNAPSHOT
- TABLE 166.TERUMO CORPORATION: OPERATING SEGMENTS
- TABLE 167.TERUMO CORPORATION: PRODUCT PORTFOLIO
- TABLE 168.TERUMO CORPORATION: NET SALES,
- TABLE 169.TERUMO CORPORATION: KEY STRATERGIES
- TABLE 170.MEDICOR ELEKTRONIKA: COMPANY SNAPSHOT
- TABLE 171.MEDICOR ELEKTRONIKA: OPERATING SEGMENTS
- TABLE 172.MEDICOR ELEKTRONIKA: PRODUCT PORTFOLIO
- TABLE 173.MEDICOR ELEKTRONIKA: NET SALES,
- TABLE 174.MEDICOR ELEKTRONIKA: KEY STRATERGIES
- TABLE 175.NINGBO DAVID MEDICAL DEVICE CO., LTD.: COMPANY SNAPSHOT
- TABLE 176.NINGBO DAVID MEDICAL DEVICE CO., LTD.: OPERATING SEGMENTS
- TABLE 177.NINGBO DAVID MEDICAL DEVICE CO., LTD.: PRODUCT PORTFOLIO
- TABLE 178.NINGBO DAVID MEDICAL DEVICE CO., LTD.: NET SALES,
- TABLE 179.NINGBO DAVID MEDICAL DEVICE CO., LTD.: KEY STRATERGIES
- TABLE 180.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: COMPANY SNAPSHOT
- TABLE 181.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: OPERATING SEGMENTS
- TABLE 182.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: PRODUCT PORTFOLIO
- TABLE 183.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: NET SALES,
- TABLE 184.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: KEY STRATERGIES
- TABLE 185.ANGIODYNAMICS: COMPANY SNAPSHOT
- TABLE 186.ANGIODYNAMICS: OPERATING SEGMENTS
- TABLE 187.ANGIODYNAMICS: PRODUCT PORTFOLIO
- TABLE 188.ANGIODYNAMICS: NET SALES,
- TABLE 189.ANGIODYNAMICS: KEY STRATERGIES
- TABLE 190.VYGON (UK) LTD: COMPANY SNAPSHOT
- TABLE 191.VYGON (UK) LTD: OPERATING SEGMENTS
- TABLE 192.VYGON (UK) LTD: PRODUCT PORTFOLIO
- TABLE 193.VYGON (UK) LTD: NET SALES,
- TABLE 194.VYGON (UK) LTD: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.NEONATAL INTENSIVE CARE MARKET SEGMENTATION
- FIGURE 2.NEONATAL INTENSIVE CARE MARKET,2021-2031
- FIGURE 3.NEONATAL INTENSIVE CARE MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.NEONATAL INTENSIVE CARE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.NEONATAL INTENSIVE CARE MARKET,BY PRODUCT,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF WARMERS NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INCUBATORS NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF MONITORING DEVICES NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF RESPIRATORY DEVICES NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PHOTOTHERAPY EQUIPMENT NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
- FIGURE 19.NEONATAL INTENSIVE CARE MARKET,BY APPLICATION,2021(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF NEONATAL HYPOTHERMIA & LOW BIRTH WEIGHT NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF JAUNDICE NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF OTHERS NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
- FIGURE 23.NEONATAL INTENSIVE CARE MARKET,BY END USER,2021(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF HOSPITALS NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
- FIGURE 25.COMPARATIVE SHARE ANALYSIS OF MATERNITY HOSPITALS NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
- FIGURE 26.COMPARATIVE SHARE ANALYSIS OF NEONATAL & PEDIATRIC HOSPITAL NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
- FIGURE 27.NEONATAL INTENSIVE CARE MARKET BY REGION,2021
- FIGURE 28.U.S. NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 29.CANADA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 30.MEXICO NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 31.GERMANY NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 32.FRANCE NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 33.UK NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 34.ITALY NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 35.SPAIN NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 36.REST OF EUROPE NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 37.CHINA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 38.JAPAN NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 39.INDIA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 40.AUSTRALIA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 41.SOUTH KOREA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 42.REST OF ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 43.BRAZIL NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 44.SAUDI ARABIA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 45.SOUTH AFRICA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
- FIGURE 46.REST OF LAMEA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILL
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook